Dublin, Aug. 20, 2021 (GLOBE NEWSWIRE) -- The "Implantable Cardiac monitors (ICM) - Market Insights, Competitive Landscape and Market Forecast - 2026" report has been added to ResearchAndMarkets.com's offering.
This 'Implantable Cardiac monitors (ICM)-Market Insights, Competitive Landscape and Market Forecast-2026' report delivers an in-depth understanding of the Implantable Cardiac monitors, historical and forecasted patient pool as well as the Implantable Cardiac monitors market trends in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
The report provides an overview of Implantable Cardiac monitors and their applications, market share of the individual devices, current and forecasted Implantable Cardiac monitors market Size from 2018 to 2026, segmented by seven major markets. The Report also covers current market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.
Implantable Cardiac monitors Overview
Implantable Cardiac monitors (ICM) also called as implantable loop recorders, are needed to assist physicians in diagnosing the cardiac rhythm of the patients, ensuring that the patient has a healthy and well-functional heart. ICM are used in continuous monitoring of the heart in case of adverse conditions such as atrial fibrillation, heart failure etc.
The monitoring can be performed in a continuous fashion for a period of two to three years, owing to the advanced level batteries with maximized durability. Hence, these devices can be used adequately in patients that require extended periods of monitoring and treatment like infrequent arrythmias. The preference for implantable cardiac monitors is increasing at a drastic rate, owing to the limited patient stay at the hospital or clinics after surgical procedures, the cost-effectiveness of these medical devices and the escalating aging population.
Industry Trends
There have been various developments and collaborations in the field of implantable cardiac monitors.
- On 7th July 2020, Medtronic Company received the U.S Food and Drug Administration (FDA) and CE Mark approval for its device LINQ II insertable cardiac monitor composed with remote programming function. In January 2019, the remotely monitoring company Geneva Healthcare announced acquisition of Geneva Healthcare, creator of a remote monitoring platform for implantable cardiac devices, for about USD 45 million in upfront cash with additional performance-based earn-out considerations of no less than USD 20 million.
- On May 20, 2020, Biotronik had announced its new alliance with Acutus Medical to create a profound portfolio of electrophysiology, mapping, ablation, and accessory products for the catheter-based treatment of cardiac arrhythmias across different markets that also included Europe and Asia. The main objective of this new alliance was to optimize patient care by combining the plethora of devices and monitors that would be linked digitally. This can take place via Biotronik's Home monitoring network with the Actus system to help transmit real-time data between physicians and patients (DAIC, 2020).
- Angel Medical Systems had partnered with Flextronics, a leading Electronics Manufacturing Services (EMS) provider that had helped as its manufacturing partner in the development of their product AngelMed Guardian system(Med Device Online, 2012).
KOL- Views
To keep up with the market trends, we take KOLs and SME's opinion working in Implantable Cardiac monitors domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging market trends in Implantable Cardiac monitor market. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.
Scope of the Report
- The report covers the descriptive overview of Implantable Cardiac monitors, explaining their applications, how they are inserted and removed, advantages, and limitations, etc.
- Additionally, an all-inclusive account of the currently available Implantable Cardiac monitors are provided, which will have an impact on the future market of Implantable Cardiac monitors.
- A detailed review of Implantable Cardiac monitors market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
- The report provides an edge while developing business strategies, by understanding the trends shaping and driving the global Implantable Cardiac monitor market.
Report Highlights
- The report covers descriptive overview of the Implantable Cardiac monitors, explaining its applications, working mechanism, etc.
- The report provides an insight into the patient population eligible for Implantation of Cardiac monitors in the 7 MM, covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.
- The report is a comprehensive account of marketed devices present in the Implantable Cardiac monitors market.
- The report also reviews the detailed global historical and forecasted Implantable Cardiac monitor devices market including assessing the outreach in 7 MM.
- The report helps in developing business strategies by understanding trends shaping and driving the global Implantable Cardiac monitors market.
Implantable Cardiac monitors Report Key Strengths
- 6 Years Forecast
- 7MM Coverage
- Competitive Landscape
- Patient Pool
- Market Size
Implantable Cardiac monitors Report Assessment
- Marketed Product profiles
- Key Products and Key Players
- Market Drivers and Barriers
- Market Forecast
- KOL'S views
Key Questions Answered
Market Insights:
- What was the Implantable Cardiac monitors Market share (%) distribution in 2018 and how it will look like in 2026?
- What will be the Implantable Cardiac monitors total market Size as well as market Size by devices across the 7MM during the forecast period (2018-2026)?
- What are the key findings pertaining to the market across 7MM and which country will have the largest Implantable Cardiac monitors market Size during the forecast period (2018-2026)?
- At what CAGR, the Implantable Cardiac monitors market is expected to grow in 7MM during the forecast period (2018-2026)?
- What will be the Implantable Cardiac monitors market outlook across the 7MM during the forecast period (2018-2026)?
- What will be the Implantable Cardiac monitors market growth till 2026 and what will be the resultant market Size in the year 2026?
- How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?
Competitive Landscape:
- What are the current devices available in the Implantable Cardiac monitors market?
- What are the Implantable Cardiac monitors available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
- How many key players are developing Implantable Cardiac monitors?
- What are the key collaborations (Industry-Industry), Mergers and acquisitions, licensing activities related to the Implantable Cardiac monitors?
- What are the key designations that have been granted for the current Implantable Cardiac monitors?
- What are the global historical and forecasted market of Implantable Cardiac monitors?
Key Topics Covered:
1 Key Insights
2 Executive Summary of Implantable Cardiac Monitors
3 Implantable Cardiac Monitors: Background and Overview
4. Company Profiles
5 Patient Testimony
6 Implantable Cardiac Monitors Devices: Competitive Analysis
7 Assumptions and Rationale- Eligible Patient Population and Market Analysis for Implantable Cardiac Monitors Devices
8 Vagus Nerve Stimulator devices: Eligible Patient Population
9 Implantable Cardiac Monitors Devices: Market Analysis
10. Market Drivers
11. Market Barriers
12. Industry Trends
13. KOL's Views
14. Analyst Views
15. PEST Analysis
16. Appendix
Companies Mentioned
- Abbott Laboratories
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- Medtronic plc
- Angel Medical Systems Inc.
For more information about this report visit https://www.researchandmarkets.com/r/3q4kzh
